The characteristic MRI findings, including frontal dominant white matter lesions and abnormal signals in the medulla oblongata, prompted us to perform genetic testing of GFAP. Considering the markedly low prevalence and wide-ranging mutation variations of AxD, reporting novel mutations with detailed clinical information is helpful for the diagnosis of AxD in suspected cases. This evidence concerns the gene GFAP and Alexander disease.